PAITON CALVERT: Open Payments
NPI 1457986671 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 61 payments from 11 companies in 2025. Trend: 2023 $1,062 · 2024 $401 · 2025 $1,253
Food & beverage: $1,075Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $462 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $199 |
| GENZYME CORPORATION | 8 | $147 |
| UCB, Inc. | 4 | $89 |
| Amgen Inc. | 4 | $73 |
| Lilly USA, LLC | 6 | $70 |
| PFIZER INC. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, ILUMYA, Bimzelx, OTEZLA, TALTZ, CIBINQO, NEMLUVIO.
Industry payments across IA — which companies pay providers there.
